Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Personal history: enhancing lesions

Farrah J Mateen1

  • 1University of Saskatchewan College of Medicine, 8-1226 College Drive, Saskatoon, SK S7N OW4, Canada. farrah_mateen@hotmail.com

Neurology
|March 23, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of Aquaporin-4 antibody in cerebrospinal fluid in neuromyelitis optica spectrum disorder.

Multiple sclerosis and related disorders·2026
Same author

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort.

Annals of clinical and translational neurology·2026
Same author

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis.

Annals of clinical and translational neurology·2025
Same author

Cognitive Status in People With Epilepsy in the Republic of Guinea: A Prospective, Case-Control Study.

Annals of clinical and translational neurology·2025
Same author

Characterizing financial toxicity among people living with neuromyelitis optica spectrum disorder.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same author

Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025